153 related articles for article (PubMed ID: 36354726)
21. Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.
Gagnière J; Dupré A; Gholami SS; Pezet D; Boerner T; Gönen M; Kingham TP; Allen PJ; Balachandran VP; De Matteo RP; Drebin JA; Yaeger R; Kemeny NE; Jarnagin WR; D'Angelica MI
Ann Surg; 2020 Jan; 271(1):147-154. PubMed ID: 29995686
[TBL] [Abstract][Full Text] [Related]
22. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases.
Mizuno T; Cloyd JM; Vicente D; Omichi K; Chun YS; Kopetz SE; Maru D; Conrad C; Tzeng CD; Wei SH; Aloia TA; Vauthey JN
Eur J Surg Oncol; 2018 May; 44(5):684-692. PubMed ID: 29551247
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations.
Passot G; Chun YS; Kopetz SE; Overman MJ; Conrad C; Aloia TA; Vauthey JN
Eur J Surg Oncol; 2016 Sep; 42(9):1378-84. PubMed ID: 27358198
[TBL] [Abstract][Full Text] [Related]
24. BRAF V600E potentially determines "Oncological Resectability" for "Technically Resectable" colorectal liver metastases.
Kobayashi S; Takahashi S; Nomura S; Kojima M; Kudo M; Sugimoto M; Konishi M; Gotohda N; Taniguchi H; Yoshino T
Cancer Med; 2021 Oct; 10(20):6998-7011. PubMed ID: 34535965
[TBL] [Abstract][Full Text] [Related]
25. Reevaluating the prognostic value of RAS mutation status in patients with resected liver metastases from colorectal cancer: A systematic review and meta-analysis.
Pikoulis E; Papaconstantinou D; Pikouli A; Wang J; Theodoridis C; Margonis GA
J Hepatobiliary Pancreat Sci; 2021 Aug; 28(8):637-647. PubMed ID: 34115442
[TBL] [Abstract][Full Text] [Related]
26. From bench to bedside: Clinical implications of KRAS status in patients with colorectal liver metastasis.
Andreatos N; Ronnekleiv-Kelly S; Margonis GA; Sasaki K; Gani F; Amini N; Wilson A; Pawlik TM
Surg Oncol; 2016 Sep; 25(3):332-8. PubMed ID: 27566041
[TBL] [Abstract][Full Text] [Related]
27. Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis.
Tosi F; Magni E; Amatu A; Mauri G; Bencardino K; Truini M; Veronese S; De Carlis L; Ferrari G; Nichelatti M; Sartore-Bianchi A; Siena S
Clin Colorectal Cancer; 2017 Sep; 16(3):e153-e163. PubMed ID: 28216246
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors differ according to KRAS mutational status: A classification and regression tree model to define prognostic groups after hepatectomy for colorectal liver metastasis.
Moro A; Mehta R; Tsilimigras DI; Sahara K; Paredes AZ; Bagante F; Guglielmi A; Alexandrescu S; Poultsides GA; Sasaki K; Aucejo FN; Pawlik TM
Surgery; 2020 Sep; 168(3):497-503. PubMed ID: 32675031
[TBL] [Abstract][Full Text] [Related]
29. Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis.
Passiglia F; Bronte G; Bazan V; Galvano A; Vincenzi B; Russo A
Crit Rev Oncol Hematol; 2016 Mar; 99():150-7. PubMed ID: 26775732
[TBL] [Abstract][Full Text] [Related]
30. The prognostic impact of resection margin status varies according to the genetic and morphological evaluation (GAME) score for colorectal liver metastasis.
Wang HW; Wang LJ; Jin KM; Bao Q; Li J; Wang K; Xing BC
J Surg Oncol; 2021 Sep; 124(4):619-626. PubMed ID: 34081792
[TBL] [Abstract][Full Text] [Related]
31. Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation.
Kawaguchi Y; Lillemoe HA; Panettieri E; Chun YS; Tzeng CD; Aloia TA; Kopetz S; Vauthey JN
J Am Coll Surg; 2019 Sep; 229(3):286-294.e1. PubMed ID: 31054911
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcome and quality of life after initial and repeat resection of colorectal liver metastasis: A retrospective analysis.
Heise D; Bayings W; Tuinhof A; Eickhoff R; Kroh A; Ulmer F; Dejong CHC; Neumann U; Binnebösel M
Int J Surg; 2017 Dec; 48():281-285. PubMed ID: 29175019
[TBL] [Abstract][Full Text] [Related]
33. Pathological diaphragmatic invasion by colorectal liver metastases is associated with RAS mutation, peritoneal recurrence and worse survival.
Okuno M; Gourmard C; Mizuno T; Omichi K; Tzeng CD; Chun YS; Lee JE; Vauthey JN; Conrad C
HPB (Oxford); 2018 Jan; 20(1):57-63. PubMed ID: 28943395
[TBL] [Abstract][Full Text] [Related]
34. RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases.
Brudvik KW; Jones RP; Giuliante F; Shindoh J; Passot G; Chung MH; Song J; Li L; Dagenborg VJ; Fretland ÅA; Røsok B; De Rose AM; Ardito F; Edwin B; Panettieri E; Larocca LM; Yamashita S; Conrad C; Aloia TA; Poston GJ; Bjørnbeth BA; Vauthey JN
Ann Surg; 2019 Jan; 269(1):120-126. PubMed ID: 28549012
[TBL] [Abstract][Full Text] [Related]
35. Clinical relevance of oncologic prognostic factors in the decision-making of pre-hepatectomy chemotherapy for colorectal cancer hepatic metastasis: the priority of hepatectomy.
Chan KM; Wu TH; Wang YC; Lee CF; Wu TJ; Chou HS; Lee WC; Chiang JM; Chen JS
World J Surg Oncol; 2018 Feb; 16(1):24. PubMed ID: 29415722
[TBL] [Abstract][Full Text] [Related]
36. Not All Kirsten Rat Sarcoma Viral Oncogene Homolog Mutations Predict Poor Survival in Patients With Unresectable Colorectal Liver Metastasis.
Lin Z; Liu Y; Cai S; Yang C; Zhou L; Li W
Technol Cancer Res Treat; 2021; 20():15330338211039131. PubMed ID: 34669528
[No Abstract] [Full Text] [Related]
37. Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?
Passot G; Kim BJ; Glehen O; Mehran RJ; Kopetz SE; Goere D; Overman MJ; Pocard M; Marchal F; Conrad C; Aloia TA; Vauthey JN; Chun YS;
Ann Surg Oncol; 2018 Jan; 25(1):179-187. PubMed ID: 29071660
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases.
Andreou A; Kopetz S; Maru DM; Chen SS; Zimmitti G; Brouquet A; Shindoh J; Curley SA; Garrett C; Overman MJ; Aloia TA; Vauthey JN
Ann Surg; 2012 Oct; 256(4):642-50. PubMed ID: 22968062
[TBL] [Abstract][Full Text] [Related]
39. RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases.
Brudvik KW; Mise Y; Chung MH; Chun YS; Kopetz SE; Passot G; Conrad C; Maru DM; Aloia TA; Vauthey JN
Ann Surg Oncol; 2016 Aug; 23(8):2635-43. PubMed ID: 27016292
[TBL] [Abstract][Full Text] [Related]
40. Liver resection for metastases from colorectal cancer in very elderly patients: New surgical horizons.
Nardo B; Serafini S; Ruggiero M; Grande R; Fugetto F; Zullo A; Novello M; Rizzuto A; Bonaiuto E; Vaccarisi S; Cavallari G; Serra R; Cannistrà M; Sacco R
Int J Surg; 2016 Sep; 33 Suppl 1():S135-41. PubMed ID: 27353843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
